Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m).

Following the acquisition, Trinity Pharma’s management will continue as minority partner, running the business under the supervision of Strides Pharma Asia.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia.”

Strides Pharma Asia is a Singaporean pharmaceutical company and a subsidiary of Strides Shasun. The acquisition will enable the company to establish its presence in South Africa.

GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia (GSAL) increasing its total stake to 75%.

The acquisition will enable the UK-based pharmaceutical company to expand its presence in Saudi Arabia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact